Stoke Therapeutics, Inc.
Stoke Therapeutics, Inc. (STOK) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 284 transactions totaling $202.3M, demonstrating a bearish sentiment with -$12.4M in net insider flow. The most recent transaction on Dec 8, 2025 involved a sale of 1,331 shares valued at $44.1K.
STOK Insider Activity Summary
Who Is Buying STOK Stock?
No significant insider buying has been recorded for STOK in the recent period.
Who Is Selling STOK Stock?
No significant insider selling has been recorded for STOK in the recent period.
Is Stoke Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for STOK is bearish with an Insider Alignment Score of 47/100 and a net flow of -$12.4M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
STOK Frequently Asked Questions
Understanding STOK Insider Activity
Insider trading at Stoke Therapeutics, Inc. (STOK) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading STOK stock, having executed 284 transactions in the past 90 days. The most active insider is Horizon Enterprise Ltd Blue (Executive), who has made 2 transactions totaling $69.0M.
Related Tools
Track Stoke Therapeutics, Inc. Insider Activity
Get notified when executives and directors at STOK file new Form 4 transactions